Publications
5674 Results
- Journal / Conference
- Clinical Lung Cancer Jul;19(4):301-314
- Year
- 2018
- Research Committee(s)
- Lung
- PMID
- PMID29396237
- Study Number(s)
- S1400A
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology [Review]
- Journal / Conference
- New England Journal of Medicine Dec 27;379(26):2517-2528
- Year
- 2018
- Research Committee(s)
- Leukemia
- PMID
- PMID30501481
- PMC
- PMC6325637
- Study Number(s)
- CTSU/A041202
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
- Journal / Conference
- Journal of Thoracic Oncology Feb;13(2):165-183
- Year
- 2018
- Research Committee(s)
- Lung
- PMID
- PMID29175116
- Study Number(s)
- S0819, S1400
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer [Review]
- Journal / Conference
- Clinical Lung Cancer Sep;19(5):377-386
- Year
- 2018
- Research Committee(s)
- Lung
- PMID
- PMID29653819
- Study Number(s)
- S1206 (8811), S1400, S1403, S1507
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy [Review]
- Journal / Conference
- Annals of Oncology, Volume 29, Issue suppl_8, 1 October 2018, mdy295.026, #1537P, poster presentation (ESMO)
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery
Medical-aid-in-dying use in the US Pacific Northwest
- Journal / Conference
- European Urology May;73(5):738-748
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID29055653
- Study Number(s)
- SWOG-8795 (INT-0094) (EST-1888)
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review [Review]
- Journal / Conference
- Breast Cancer Research and Treatment 171 (2):325-334
- Year
- 2018
- Research Committee(s)
- Breast
- PMID
- PMID29789969
- PMC
- PMC6076849
- Study Number(s)
- CTSU/C40503
Identification of Risk Factors for Toxicity in Patients With Hormone Receptor-Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study
- Journal / Conference
- Journal of Cancer Survivorship:Research and Practice, 2017 Feb;11(1):32-40; 2016 Jul 12 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Lymphoma
- PMID
- PMID27405732
- PMC
- PMC5233644
- Study Number(s)
- SWOG-9133, SWOG-9208
Seven year follow-up for energy/vitality outcomes in early stage hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208
- Journal / Conference
- Biology of Blood and Marrow Transplantation Apr;23(4):691-696; Epub 2017 Jan 3.
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID28062215
- PMC
- PMC5465962
- Study Number(s)
- S0333
Next-generation sequencing in adult B cell acute lymphoblastic leukemia patients
- Journal / Conference
- Cancer Jul 1;123(13):2444-2451. Epub 2017 May 2.
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28464211